Larson Financial Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12K Sell
608
-456
-43% -$11.4K ﹤0.01% 2415
2026
Q2
$30.4K Buy
1,064
+28
+3% +$889 ﹤0.01% 1768
2026
Q1
$32.6K Buy
1,036
+171
+20% +$5.39K ﹤0.01% 1587
2025
Q4
$25.5K Buy
865
+240
+38% +$6.67K ﹤0.01% 1579
2025
Q3
$15.8K Sell
625
-35
-5% -$853 ﹤0.01% 1773
2025
Q2
$15.8K Sell
660
-231
-26% -$5.36K ﹤0.01% 1588
2025
Q1
$20.4K Buy
891
+811
+1,014% +$19.6K ﹤0.01% 1358
2024
Q4
$2.03K Buy
+80
New +$2.03K ﹤0.01% 1880
2024
Q1
– Sell
-101
Closed -$2.89K – 1883
2023
Q4
$2.89K Hold
101
– – ﹤0.01% 1298
2023
Q3
$3.74K Hold
101
– – ﹤0.01% 1242
2023
Q2
$3.94K Hold
101
– – ﹤0.01% 1151
2023
Q1
$3.69K Hold
101
– – ﹤0.01% 1146
2022
Q4
$3.11K Buy
+101
New +$3.14K ﹤0.01% 1125

Other funds holding RTO

Larson Financial Group's RTO Position: Q3 2026 in Review

Larson Financial Group reduced its Rentokil (RTO) stake by 43% in Q3 2026, selling an estimated $11.4K and leaving 608 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

Larson Financial Group first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. The position peaked at $32.6K in Q1 2026. 258 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Larson Financial Group held 608 shares of Rentokil worth $12K as of Q3 2026.
  • Larson Financial Group sold 456 Rentokil shares in Q3 2026, an estimated $11.4K.
  • Rentokil made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2415 holding.
  • Larson Financial Group first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • Larson Financial Group's Rentokil position peaked at $32.6K in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.